<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Risk factors for the development of active tuberculosis among persons infected with &lt;em&gt;Mycobacterium tuberculosis&lt;/em&gt;</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Risk factors for the development of active tuberculosis among persons infected with <em>Mycobacterium tuberculosis</em></h1>
<div class="graphic"><div class="figure"><div class="ttl">Risk factors for the development of active tuberculosis among persons infected with <em>Mycobacterium tuberculosis</em></div><div class="cntnt"><table cellspacing="0"><colgroup span="2" width="42%"></colgroup><colgroup width="16%"></colgroup> <tbody> <tr> <td class="subtitle1">Risk factor</td> <td class="subtitle1">Estimated risk for TB relative to persons with no known risk factor</td> <td class="subtitle1">References</td> </tr> <tr> <td class="subtitle2_left" colspan="3">High risk</td> </tr> <tr> <td class="indent1">Acquired immunodeficiency syndrome (AIDS)</td> <td>110 to 170</td> <td>1,2</td> </tr> <tr> <td class="indent1">Human immunodeficiency virus infection (HIV)</td> <td>50 to 110</td> <td>3,4</td> </tr> <tr> <td class="indent1">Transplantation (related to immune-suppressant therapy)</td> <td>20 to 74</td> <td>5 to 8</td> </tr> <tr> <td class="indent1">Silicosis</td> <td>30</td> <td>9,10</td> </tr> <tr> <td class="indent1">Chronic renal failure requiring hemodialysis</td> <td>10 to 25</td> <td>11 to 14</td> </tr> <tr> <td class="indent1">Carcinoma of head and neck</td> <td>16.0</td> <td>15</td> </tr> <tr> <td class="indent1">Recent tuberculosis (TB) infection (≤2 years)</td> <td>15.0</td> <td>16,17</td> </tr> <tr> <td class="indent1">Abnormal chest radiograph with apical fibronodular changes typical of healed TB (not granuloma)</td> <td>6 to 19</td> <td>18 to 20</td> </tr> <tr> <td class="indent1">Tumor necrosis factor (TNF)-alpha inhibitors</td> <td>1.7 to 9</td> <td>21,22,35,36</td> </tr> <tr> <td class="subtitle2_left" colspan="3">Moderate risk</td> </tr> <tr> <td class="indent1">Treatment with glucocorticoids</td> <td>4.9</td> <td>23</td> </tr> <tr> <td class="indent1">Diabetes mellitus (all types)</td> <td>2 to 3.6</td> <td>24 to 27,37</td> </tr> <tr> <td class="indent1">Young age when infected (≤4 years)</td> <td>2.2 to 5</td> <td>28</td> </tr> <tr> <td class="subtitle2_left" colspan="3">Slightly increased risk</td> </tr> <tr> <td class="indent1">Underweight (&lt;85 percent of ideal body weight); for most individuals this is equivalent to body mass index (BMI) ≤20</td> <td>2 to 3</td> <td>29</td> </tr> <tr> <td class="indent1">Cigarette smoker (1 pack/day)</td> <td>2 to 3</td> <td>30,31</td> </tr> <tr> <td class="indent1">Chest radiograph with solitary granuloma</td> <td>2</td> <td>20,32</td> </tr> <tr> <td class="subtitle2_left" colspan="3">Low risk</td> </tr> <tr> <td class="indent1">Infected person, no known risk factor, normal chest radiograph ("low-risk reactor")</td> <td>1</td> <td>33</td> </tr> <tr> <td class="subtitle2_left" colspan="3">Very low risk</td> </tr> <tr> <td class="indent1">Positive booster (two-step test) with no other known risk factor and normal chest radiograph)</td> <td>0.5</td> <td>Extrapolated from 33 and 34</td> </tr> </tbody></table></div><div class="graphic_reference">References:<br/><ol>
<li>Guelar A, Gatell JM, Verdejo J, et al. A prospective study of the risk of tuberculosis among HIV-infected patients. AIDS 1993; 7:1345.</li>
<li>Antonucci G, Girardi E, Raviglione MC, et al. Risk factors for tuberculosis in HIV-infected persons. A prospective cohort study. JAMA 1995; 274:143.</li>
<li>Wood R, Maartens G, Lombard CJ. Risk factors for developing tuberculosis in HIV-1 - Infected adults from communities with low or very high incidence of tuberculosis. J Acquir Immune Defic Syndr 2000; 23:75.</li>
<li>Selwyn PA, Hartel D, Lewis VA, et al. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. New Engl J Med 1989; 320:545.</li>
<li>Sakhuja V, Jha V, Varma PP, et al. The high incidence of tuberculosis among renal transplant recipients in India. Transplantation 1996; 61:211.</li>
<li>Aguado JM, Herrero JA, Gavalda J, et al. Clinical presentation and outcome of tuberculosis in kidney, liver, and heart transplant recipients in Spain. Spanish Transplantation Infection Study Group, GESITRA. Transplantation 1997; 63:1278.</li>
<li>Miller RA, Lanza LA, Kline JN, Geist LJ. Mycobacterium tuberculosis in lung transplant recipients. Am J Respir Crit Care Med 1995; 152:374.</li>
<li>Meyers BR, Halpern M, Sheiner P, et al. Tuberculosis in liver transplant patients. Transplantation 1994; 58:301.</li>
<li>Hong Kong Chest Service/Tuberculosis Research Centre, Madras/British Medical Research Council. A Double-blind placebo-controlled clinical trial of three antituberculosis chemoprophylaxis regimens in patients with silicosis in Hong Kong. Am Rev Respir Dis 1992; 145:36.</li>
<li>Cowie RL. The epidemiology of tuberculosis in gold miners with silicosis. Am J Respir Crit Care Med 1994; 150:1460.</li>
<li>Malhotra KK, Parashar MK, Sharma RK, et al. Tuberculosis in maintenance haemodialysis patients. Study from an endemic area. Postgrad Med J 1981; 57:492.</li>
<li>Lundin AP, Adler AJ, Berlyne GM, Friedman EA. Tuberculosis in patients undergoing maintenance hemodialysis. Am J Med 1979; 67:597.</li>
<li>Andrew OT, Schoenfeld PY, Hopewell PC, Humphreys MH. Tuberculosis in patients with end-stage renal disease. Am J Med 1980; 68:59.</li>
<li>Pradhan RP, Katz LA, Nidus BD, et al. Tuberculosis in dialyzed patients. JAMA 1974; 229:798.</li>
<li>Rieder HL, Cauthen GM, Comstock GW, Snider DE Jr. Epidemiology of tuberculosis in the United States. Epidemiol Rev 1989; 11:79.</li>
<li>Sutherland I. Recent studies in the epidemiology of tuberculosis, based on the risk of being infected with tubercle bacilli. Adv Tuberc Res 1976; 19:1.</li>
<li>Sutherland I. The evolution of clinical tuberculosis in adolescents. Tuberc 1966; 47:308.</li>
<li>Nolan CM, Elarth AM. Tuberculosis in a cohort of Southeast Asian refugees: A five-year surveillance study. Am Rev Resp Dis 1988; 137:805.</li>
<li>Grzybowksi S, McKinnon NE, Tuters L, et al. Reactivations in inactive pulmonary tuberculosis. Am Rev Resp Dis 1966; 93:352. </li>
<li>Grzybowski S, Fishaut H, Rowe J, Brown A. Tuberculosis among patients with various radiologic abnormalities, followed by the chest clinic service. Am Rev Resp Dis 1971; 104:605. </li>
<li>Keane J, Gershon S, Wise RP, et al. Tuberculosis associated with infliximab, a tumor necrosis factor ? - neutralizing agent. N Engl J Med 2001; 345:1098. </li>
<li>Brassard P, Kezouh A, Suissa S. Antirheumatic drugs and the risk of tuberculosis. Clin Infect Dis 2006; 43:717. </li>
<li>Jick SS, Lieberman ES, Rahman MU, Choi HK. Glucocorticoid use, other associated factors, and the risk of tuberculosis. Arthritis Rheum 2006; 55:19. </li>
<li>Kim SJ, Hong YP, Lew WJ, et al. Incidence of pulmonary tuberculosis among diabetics. Tuber Lung Dis 1995; 76:529. </li>
<li>Silwer H, Oscarsson PN. Incidence and coincidence of diabetes mellitus and pulmonary tuberculosis in a Swedish county. Acta Med Scand 1958; 161:1. </li>
<li>Pablos-Mendez A, Blustein J, Knirsch CA. The role of diabetes mellitus in the higher prevalence of tuberculosis among Hispanics. Am J Public Health 1997; 87:574. </li>
<li>Boucot KR. Diabetes mellitus and pulmonary tuberculosis. J Chronic Dis 1957; 6:256. </li>
<li>Comstock GW, Livesay VT, Woolpert SF. The prognosis of a positive tuberculin reaction in childhood and adolescence. Am J Epidemiol 1974; 99:131. </li>
<li>Comstock GW. Frost Revisited: The modern epidemiology of tuberculosis. Am J Epidemiol 1975; 101:263. </li>
<li>Maurya V, Vijayan VK, Shah A. Smoking and tuberculosis: an association overlooked. Int J Tuberc Lung Dis 2002; 6:942. </li>
<li>Gajalakshmi V, Peto R, Kanaka T, Jha P. Smoking and mortality from tuberculosis and other diseases in India: retrospective study of 43000 adult male deaths and 35000 controls. Lancet 2003; 362:507. </li>
<li>Horwitz O, Wilbek E, Erickson PA. Epidemiological basis of tuberculosis eradication. Longitudinal studies on the risk of tuberculosis in the general population of a low-prevalence area. Bull World Health Organ 1969; 41:95.</li>
<li>Comstock GW, Edwards LB, Livesay VT. Tuberculosis morbidity in the US Navy: its distribution and decline. Am Rev Respir Dis 1974; 110:572. </li>
<li>Ferebee SH. Controlled chemoprophylaxis trials in tuberculosis. Adv Tuberc Res 1969; 17:28. </li>
<li>Wolfe F, Michaud K, Anderson J, et al. Tuberculosis infection in patients with rheumatoid arthritis and the effect of infliximab therapy. Arthritis Rheum 2004; 50:372. </li>
<li>Carmona L, Gómez-Reino JJ, Rodríguez-Valverde V, et al. Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists. Arthritis Rheum 2005; 52:1766.</li>
<li>Lee MR, Huang YP, Kuo YT, et al. Diabetes mellitus and latent tuberculosis infection: a systemic review and meta-analysis. Clin Infect Dis 2016; pii:ciw836.</li></ol></div><div id="graphicVersion">Graphic 60941 Version 7.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
